Evidence map›Paper›PMID 39525959›Full record

ArticleFrontiers in chemistry2024

A complementary approach for detecting biological signals through a semi-automated feature selection tool.

Gabriel Santos Arini, Luiz Gabriel Souza Mencucini, Rafael de Felício, Luís Guilherme Pereira Feitosa, Paula Rezende-Teixeira, Henrique Marcel Yudi de Oliveira Tsuji, Alan Cesar Pilon, Danielle Rocha Pinho, Letícia Veras Costa Lotufo, Norberto Peporine Lopes and 2 more

Abstract read
In one paragraph

Article in Frontiers in chemistry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Gabriel Santos AriniDepartment of Biomolecular Sciences, Computational Chemical Biology Laboratory, School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, Ribeirão Preto, Brazil.
Luiz Gabriel Souza MencuciniDepartment of Biomolecular Sciences, Computational Chemical Biology Laboratory, School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, Ribeirão Preto, Brazil.
Rafael de FelícioBrazilian Biosciences National Laboratory (LNBio), Brazilian Center for Research in Energy and Materials (CNPEM), Campinas, Brazil.
Luís Guilherme Pereira FeitosaNPPNS, Department of Biomolecular Sciences, School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, Ribeirão Preto, Brazil.
Paula Rezende-TeixeiraDepartment of Pharmacology, Marine Pharmacology Laboratory, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil.
Henrique Marcel Yudi de Oliveira TsujiDepartment of Biomolecular Sciences, Computational Chemical Biology Laboratory, School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, Ribeirão Preto, Brazil.
Alan Cesar PilonDepartment of Biochemistry and Organic Chemistry, Institute of Chemistry, Paulista State University, São Paulo, Brazil.
Danielle Rocha PinhoNPPNS, Department of Biomolecular Sciences, School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, Ribeirão Preto, Brazil.
Letícia Veras Costa LotufoDepartment of Pharmacology, Marine Pharmacology Laboratory, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil.
Norberto Peporine LopesNPPNS, Department of Biomolecular Sciences, School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, Ribeirão Preto, Brazil.
Daniela Barretto Barbosa TrivellaBrazilian Biosciences National Laboratory (LNBio), Brazilian Center for Research in Energy and Materials (CNPEM), Campinas, Brazil.
Ricardo Roberto da SilvaDepartment of Biomolecular Sciences, Computational Chemical Biology Laboratory, School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, Ribeirão Preto, Brazil.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Untargeted metabolomics is often used in studies that aim to trace the metabolic profile in a broad context, with the data-dependent acquisition (DDA) mode being the most commonly used method. However, this approach has the limitation that not all detected ions are fragmented in the data acquisition process, in addition to the lack of specificity regarding the process of fragmentation of biological signals. The present work aims to extend the detection of biological signals and contribute to overcoming the fragmentation limits of the DDA mode with a dynamic procedure that combines experimental and in silico approaches. Methods: Metabolomic analysis was performed on three different species of actinomycetes using liquid chromatography coupled with mass spectrometry. The data obtained were preprocessed by the MZmine software and processed by the custom package RegFilter. Results and Discussion: RegFilter allowed the coverage of the entire chromatographic run and the selection of precursor ions for fragmentation that were previously missed in DDA mode. Most of the ions selected by the tool could be annotated through three levels of annotation, presenting biologically relevant candidates. In addition, the tool offers the possibility of creating local spectral libraries curated according to the user's interests. Thus, the adoption of a dynamic analysis flow using RegFilter allowed for detection optimization and curation of potential biological signals, previously absent in the DDA mode, being a good complementary approach to the current mode of data acquisition. In addition, this workflow enables the creation and search of in-house tailored custom libraries.

Indexed as

chemometricsdata dependent acquisitionmass spectrometrynatural productsuntargeted metabolomics

Identifiers

PMID39525959
PMCPMC11543558

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.